How Investors Are Reacting To Gilead Sciences (GILD) Expanding Liver And Oncology Drug Footprint

Simply Wall St. · 2026-06-03T00:16:08Z

Gilead Sciences (GILD) Announces New Results From a Post Hoc Analysis

Insider Monkey · 2026-06-02T14:14:01Z

Gilead Sciences, Inc. (GILD) Gains Attention as Livdelzi Demonstrates Long-Term Efficacy and Safety

Insider Monkey · 2026-06-02T14:11:21Z

How Is Gilead Sciences's Stock Performance Compared to Other Healthcare Stocks

Barchart · 2026-06-02T09:53:35Z

H.C. Wainwright Maintains Buy Rating on Tempus AI (TEM) Following Strong Revenue Growth

Insider Monkey · 2026-06-02T09:38:04Z

3 Stocks Estimated To Be Trading At Discounts Ranging From 24% To 49.9%

Simply Wall St. · 2026-06-01T17:38:34Z

Gilead (GILD) to Showcase New Cancer Therapy Data

Insider Monkey · 2026-06-01T13:43:39Z

Natera And 2 Other Companies That May Be Trading Below Their Estimated Value

Simply Wall St. · 2026-06-01T11:38:42Z

Three Stocks That May Be Trading Below Estimated Value In May 2026

Simply Wall St. · 2026-05-29T17:38:14Z

Discover May 2026's Stocks That Could Be Trading Below Estimated Value

Simply Wall St. · 2026-05-29T11:37:57Z